prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
38556,3.60343110000e+16,95352020,53,Methylnaltrexone bromide 12mg/0.6ml solution for injection vials,Methylnaltrexone bromide,20mg/1ml,Solution for injection,Subcutaneous,Peripheral Opioid-Receptor Antagonists,February 2009,16288001,,,,,,,,,0,1060600
65060,3.01971110000e+16,53963021,2231,Naloxegol 25mg tablets,Naloxegol oxalate,25mg,Tablet,Oral,Peripheral Opioid-Receptor Antagonists,December 2015,53963021,,,,,,,,,0,1060600
39986,1.37995110000e+16,95354020,69,Relistor 12mg/0.6ml solution for injection vials (Bausch & Lomb UK Ltd),Methylnaltrexone bromide,20mg/1ml,Solution for injection,Subcutaneous,Peripheral Opioid-Receptor Antagonists,August 2009,16289001,,,,,,,,,0,1060600
66723,3.01708110000e+16,53964021,161,Moventig 25mg tablets (Kyowa Kirin Ltd),Naloxegol oxalate,25mg,Tablet,Oral,Peripheral Opioid-Receptor Antagonists,July 2016,53964021,,,,,,,,,0,1060600
70074,3.01698110000e+16,53962021,121,Moventig 12.5mg tablets (Kyowa Kirin Ltd),Naloxegol oxalate,12.5mg,Tablet,Oral,Peripheral Opioid-Receptor Antagonists,September 2017,53962021,,,,,,,,,0,1060600
65870,3.01970110000e+16,53961021,767,Naloxegol 12.5mg tablets,Naloxegol oxalate,12.5mg,Tablet,Oral,Peripheral Opioid-Receptor Antagonists,April 2016,53961021,,,,,,,,,0,1060600
